34 filings
8-K
FDMT
4D Molecular Therapeutics Inc
9 May 24
4DMT Reports First Quarter 2024 Financial Results and Operational Highlights
4:22pm
8-K
FDMT
4D Molecular Therapeutics Inc
29 Feb 24
4DMT Reports Full Year 2023 Financial Results and Operational Highlights
4:12pm
8-K
FDMT
4D Molecular Therapeutics Inc
9 Feb 24
Other Events
4:56pm
8-K
FDMT
4D Molecular Therapeutics Inc
4 Jan 24
Departure of Directors or Certain Officers
8:30am
8-K
FDMT
4D Molecular Therapeutics Inc
22 Nov 23
Amendments to Articles of Incorporation or Bylaws
4:20pm
8-K
j9y1hh rb
9 Nov 23
4DMT Reports Third Quarter 2023 Financial Results and Operational Highlights
4:23pm
8-K
5tvnf1u1d9
12 Sep 23
Departure of Directors or Certain Officers
9:17pm
8-K
dszeu 8cs
9 Aug 23
4D Molecular Therapeutics Reports Second Quarter 2023 Financial Results
4:26pm
8-K
lo77l7269x
10 Jul 23
Entry into a Material Definitive Agreement
9:31pm
8-K
3gws7by xpg
25 May 23
Submission of Matters to a Vote of Security Holders
4:58pm
8-K
72q8f dgj
10 May 23
4D Molecular Therapeutics Reports First Quarter 2023 Financial Results
6:08pm
8-K
fwhw6 vmo7os
9 May 23
Other Events
4:43pm
8-K
ib6r9h5o
15 Mar 23
4D Molecular Therapeutics Reports Full Year 2022 Financial Results
4:15pm
8-K
svxgxk
2 Feb 23
Other Events
7:08pm
8-K
4d95avqbhjv4qxon
26 Jan 23
Other Events
4:50pm
8-K
fyuaq5w t7the
9 Nov 22
4D Molecular Therapeutics Reports Third Quarter 2022 Financial Results
4:08pm
8-K
6bq0v7
27 Sep 22
Departure of Directors or Certain Officers
4:25pm
8-K
fhhponxo
11 Aug 22
4D Molecular Therapeutics Reports Second Quarter 2022 Financial Results and Provides 4D-310 Program Update
4:19pm
8-K
ln207sy6
17 Jun 22
Amendments to Articles of Incorporation or Bylaws
7:52pm
8-K
b4zr1mn
27 May 22
Submission of Matters to a Vote of Security Holders
5:24pm